ADAG Adagene Inc.

NEUTRAL Impact: 5/10 424B5
Horizon weeks Filed Apr 2, 2026 Processed 2mo ago SEC 0001104659-26-038861
Notable filing: 424B5
Latest settled — T+20d ⚠ clustered
ADAG ▼ -7.77% at T+20d
NEUTRAL call ✗ call lost -7.77% · α vs SPY -17.65% · entry $3.99 → $3.68
Next anchor: T+60d in 20d
Last close $3.26 (close Jun 8) · -18.30% from $3.99 entry
Entry anchored
Apr 1, 03:53 PM ET
via Databento tick
T+1d
+8.27%
call +8.27% · α +7.79%
$4.32
settled 2mo ago
T+5d
-4.76%
call -4.76% · α -8.38%
$3.80
settled 2mo ago
T+20d
-7.77%
call -7.77% · α -17.65%
$3.68
settled 6w ago
T+60d
call — · α —
in 20d

Price Chart

Loading chart...

Executive Summary

Adagene Inc. is conducting a preliminary prospectus supplement for a public offering of American Depositary Shares (ADSs) to raise capital. The offering is subject to completion and does not specify the number of ADSs or the offering price. The company intends to use the net proceeds primarily for research and development activities on its pipeline candidates, including ADG126, ADG138, and other programs, and for general corporate purposes. The offering is being managed by Leerink Partners and LifeSci Capital, with Lucid Capital Markets as co-manager. The company faces risks related to its status as a Cayman Islands holding company with operations in China, including regulatory scrutiny, potential delisting due to PCAOB inspection issues, and the need to file with the CSRC post-offering.

Actionable Insight

Investors should monitor the final prospectus for the specific number of ADSs being offered and the offering price, as well as the company's ability to comply with regulatory requirements in China, including the CSRC filing and PCAOB inspection issues. The company's status as a potential PFIC could have significant tax implications for U.S. investors, which should be considered in investment decisions.

Key Facts

  • Adagene Inc. is offering an unspecified number of ADSs, each representing 1.25 ordinary shares.
  • The net proceeds from the offering will be used to fund research and development activities on pipeline candidates, including ADG126, ADG138, and other programs, and for general corporate purposes.
  • The offering is being managed by Leerink Partners and LifeSci Capital, with Lucid Capital Markets as co-manager.
  • The company is subject to risks related to its status as a Cayman Islands holding company with operations in China, including regulatory scrutiny, potential delisting due to PCAOB inspection issues, and the need to file with the CSRC post-offering.
  • The company was likely a passive foreign investment company (PFIC) for 2025 and there is a significant risk it will be a PFIC for 2026, which could have adverse U.S. federal income tax consequences for investors.

Financial Impact

The net proceeds from the offering will be used to fund research and development activities on pipeline candidates, including ADG126, ADG138, and other programs, and for general corporate purposes.

cashdilutionresearch and development expenses

Risk Factors

  • Regulatory risks related to the company's status as a Cayman Islands holding company with operations in China, including potential delisting due to PCAOB inspection issues.
  • The need to file with the CSRC post-offering, which could delay or prevent the offering.
  • The company's status as a potential PFIC, which could have adverse U.S. federal income tax consequences for investors.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001104659-26-038861
Document: 0001104659-26-038861-index-headers.html0001104659-26-038861
Document: 0001104659-26-038861-index.html0001104659-26-038861
Document: 0001104659-26-038861.txt0001104659-26-038861
8 reports for ADAG
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+1▲ +8.27%Apr 1, 2026
Filters
Rows
Reports for ADAG — sortable, filterable
Type Now
Apr 17, 2026
7w ago
6-K
BULLISH ★ 8/10
$3.89 $3.39▼ −12.85%▼ −17.06%$3.26 (−16.20%)
Apr 2, 2026
9w ago
6-K
BEARISH ★ 7/10
$3.99 $3.68▲ +7.77%▲ +17.65%$3.26 (+18.30%)
Apr 2, 2026
9w ago
Press Release
NEUTRAL ★ 5/10
$3.99 $3.68▼ −7.77%▼ −17.65%$3.26 (−18.30%)
Apr 2, 2026
9w ago
424B5
NEUTRAL ★ 5/10
$3.99 $3.68▼ −7.77%▼ −17.65%$3.26 (−18.30%)
Apr 2, 2026
9w ago
Press Release
BULLISH ★ 7/10
$3.99 $3.68▼ −7.77%▼ −17.65%$3.26 (−18.30%)
Apr 2, 2026
9w ago
Press Release
BULLISH ★ 8/10
$3.99 $3.68▼ −7.77%▼ −17.65%$3.26 (−18.30%)
Apr 1, 2026
9w ago
20-F / 6-K
BULLISH ★ 7/10
$3.99 $3.68▼ −7.77%▼ −17.65%$3.26 (−18.30%)
Mar 17, 2026
12w ago
Press Release
NEUTRAL ★ 5/10
$3.94 $3.85▼ −2.28%▼ −8.33%$3.26 (−17.26%)
Showing 8 of 8

US Market Status

Market Closed — Opens in 5h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access